Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

Wei-Wei Zhang,1,2 Feng Bai,1 Jin Wang,1 Rong-Hua Zheng,1 Li-Wang Yang,1 Erskine A James,3 Zhi-Qing Zhao1,4 1Department of Physiology, Shanxi Medical University, 2Department of Anesthesiology, Shanxi Provincial People’s Hospital, Taiyuan, Shanxi, China; 3Department of Internal Medicine, Na...

Full description

Bibliographic Details
Main Authors: Zhang WW, Bai F, Wang J, Zheng RH, Yang LW, James EA, Zhao ZQ
Format: Article
Language:English
Published: Dove Medical Press 2017-10-01
Series:Drug Design, Development and Therapy
Subjects:
angiotensin II receptor
cardiac fibrosis
cardiac function
edaravone
heart failure
Online Access:https://www.dovepress.com/edaravone-inhibits-pressure-overload-induced-cardiac-fibrosis-and-dysf-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/edaravone-inhibits-pressure-overload-induced-cardiac-fibrosis-and-dysf-peer-reviewed-article-DDDT

Similar Items